Serum Concentration Monitoring of Cardiac Glycosides

Dobbs, R. J.; O'neill, C. J. A.; Deshmukh, A. A.; Nicholson, P. W.; Dobbs, S. M.

doi:10.2165/00003088-199120030-00001

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1994

2015

Publication Types

Select...

Article4

Book2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 18 publications

(1 citation statement)

References 94 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It should also be noted that the trough plasma levels of digoxin after repeated once‐daily oral dosing in patients with Parkinson’s disease with 0.125 mg digoxin obtained in this study are within the same range quoted for patients in the literature [ 7]. Changes in trough levels of digoxin are believed to be the most reliable way of assessing steady‐state concentrations of digoxin [ 8, 9], and therefore the clinical significance of an interaction. Changes in C max are too readily influenced by other factors.…”

Section: Discussionsupporting

confidence: 75%

The effect of steady‐state ropinirole on plasma concentrations of digoxin in patients with Parkinson’s disease

Taylor

Beerahee

Citerone

et al. 1999

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 75%

The effect of steady‐state ropinirole on plasma concentrations of digoxin in patients with Parkinson’s disease

Taylor

Beerahee

Citerone

et al. 1999

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

Simultaneous quantification of digoxin, digitoxin, and their metabolites in serum using high performance liquid chromatography‐tandem mass spectrometry

Bylda

Thiele

Kobold

et al. 2015

Drug Testing and Analysis

View full text Add to dashboard Cite

show abstract

Therapeutic Drug Monitoring in Pediatrics: A Need for Improvement

Tange

Grey

Senécal

1994

The Journal of Clinical Pharma

View full text Add to dashboard Cite

Therapeutic drug monitoring (TDM) is practiced for a number of frequently used drugs in infants and children. It is believed that monitoring drug levels will increase the probability of a therapeutic response and minimize the probability of adverse drug sequelae. Dose adjustments are based on measured drug levels interpreted relative to published therapeutic ranges which may or may not reflect the true relationship with either therapeutic or adverse effects. Potential errors derive from many sources, some amenable to solutions based on current knowledge, others awaiting improved understanding of the causes and consequences of unreliable therapeutic ranges.

show abstract

Serum Concentration Monitoring of Cardiac Glycosides

Cited by 18 publications

References 94 publications

The effect of steady‐state ropinirole on plasma concentrations of digoxin in patients with Parkinson’s disease

The effect of steady‐state ropinirole on plasma concentrations of digoxin in patients with Parkinson’s disease

Simultaneous quantification of digoxin, digitoxin, and their metabolites in serum using high performance liquid chromatography‐tandem mass spectrometry

Therapeutic Drug Monitoring in Pediatrics: A Need for Improvement

Contact Info

Product

Resources

About